Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 4Pain 3Neoplasms 3Breast Neoplasms 2Urinary Bladder Neoplasms 1Pneumonia 1Patient Satisfaction 1Paget Disease, Extramammary 1Operable Breast Cancer 1Myofascial Pain Syndromes 1Lymphoma, Follicular 1Lung Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Chronic Pain 1Cancer Pain 1Agnosia 1

Interventions

Morphine 6nabiximols 4Oxycodone 3Fentanyl 3Methadone 2Hydromorphone 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1resiniferatoxin 1naloxegol 1Tapentadol 1Sugars 1Standard of Care 1Lidocaine 1Inosine Monophosphate 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cancer Pain × Lidocaine × Clear all
NCT04703803 2023-04-25

Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care

University of Sao Paulo

Phase 3 Completed
30 enrolled

Cancer Pain, Myofascial Pain Syndromes, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡